HIMS & HERS Aktie

 

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or......

SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......

Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy as Hims & Hers continues to expand internationallySAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced two new clinical experts will join its global medical leadership team, led by Global Chief Medical Officer Pat Carroll, MD. Kultar Garcha, MD, will serve as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, will serve as Chief Medical Officer of Hims Australia. The appointments mark the company's latest step in strengthening the local clinical leadership that underpins its international growth and pursuit to deliver access to personalized care. "We believe the only way to grow internationally is to invest in leaders who have a deep understanding and expertise in these markets," said...

SAN DIEGO, Sept. 30, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, all dates inclusive (the "Class Period"), have until November 2, 2026 to seek......

SAN DIEGO, Sept. 29, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29,......

SAN FRANCISCO, Sept. 29, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......

NEW YORK, Sept. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead......

SAN FRANCISCO, Sept. 25, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or......

SAN FRANCISCO, Sept. 24, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $28.39, moving 6.7% from the previous trading session....

SAN FRANCISCO, Sept. 23, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......

Okupe, Oluyemi - Vorstand - Tag der Transaktion: 2026-09-22...

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026......

Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims & Hers Health, Inc. (NYSE: HIMS) What: Securities fraud class action lawsuit filed Class Period: August 4, 2025 through July 29, 2026 Deadline to Seek Lead Plaintiff Status:......

LOS ANGELES, Sept. 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. IF YOU SUFFERED A LOSS ON YOUR HIMS & HERS HEALTH, INC. INVESTMENTS, CLICK......

BENSALEM TOWNSHIP, Pa., Sept. 21, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS......

SAN FRANCISCO, Sept. 21, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......

The insider still retains significant holdings, valued at $8.5 million, despite the sale....

NEW ORLEANS, Sept. 18, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company")......